HomeKLDO • OTCMKTS
add
Kaleido Biosciences Inc
Previous close
$0.00010
Market cap
4.26K USD
Avg Volume
536.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2021info | Y/Y change |
|---|---|---|
Revenue | 1.10M | 13.23% |
Operating expense | 20.82M | -13.51% |
Net income | -90.29M | -10.62% |
Net profit margin | -8.18K | 2.31% |
Earnings per share | -2.16 | 11.48% |
EBITDA | -85.16M | -10.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.47M | -16.76% |
Total assets | 50.14M | -15.51% |
Total liabilities | 39.53M | 1.76% |
Total equity | 10.61M | — |
Shares outstanding | 42.62M | — |
Price to book | 0.00 | — |
Return on assets | -99.93% | — |
Return on capital | -148.23% | — |
Cash Flow
Net change in cash
| (USD) | 2021info | Y/Y change |
|---|---|---|
Net income | -90.29M | -10.62% |
Cash from operations | -77.09M | -25.32% |
Cash from investing | -691.00K | 82.83% |
Cash from financing | 70.04M | 73.36% |
Net change in cash | -7.75M | 69.18% |
Free cash flow | -46.02M | -25.29% |
About
Founded
2015
Headquarters
Website
Employees
76
